NCT07145073View on ClinicalTrials.gov

Repetitive Transcranial Alternating Current Stimulation (rtACS) for the Treatment of Optic Neuropathies

NANot yet recruitingINTERVENTIONAL
Enrollment

188

Participants

Timeline

Start Date

September 1, 2025

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2028

Conditions
Glaucoma
Interventions
DEVICE

DC-Stimulator MC

Experimental：Participants will receive 10 days of repeated transcranial alternating current stimulation treatment in hospital.

DEVICE

DC-Stimulator MC

Sham Comparator：Participants will receive 10 days of repeated transcranial alternating current stimulation treatment (no active stimulation) in hospital.

Trial Locations (1)

100

National Taiwan University Hospital, Taipei

All Listed Sponsors
lead

National Taiwan University Hospital

OTHER

NCT07145073 - Repetitive Transcranial Alternating Current Stimulation (rtACS) for the Treatment of Optic Neuropathies | Biotech Hunter | Biotech Hunter